Dermatology
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Feature
Camp Discovery: A place for children to be comfortable in their own skin
Chronic skin conditions carry a heavy psychological burden, but a special 1-week camp for youth 8-16 founded 30 years ago aims to lift that weight...
Latest News
New guidelines for MTX use in pediatric inflammatory skin disease unveiled
One of the recommendations states that liver biopsy is not indicated for routine monitoring of pediatric patients taking low-dose MTX.
Latest News
For psoriasis, review finds several biosimilars as safe and effective as biologics
“The biosimilars evaluated in this study could be considered alongside originators for biologic-naive patients to improve the accessibility of...
Latest News
Study points to need to improve identification of culprit in SJS/TEN cases
A single culprit drug was labeled in 17 cases, but physicians communicated certainty in only 7 of those cases.
News from the FDA/CDC
FDA approves ritlecitinib for ages 12 and up for alopecia areata
It is the second JAK inhibitor approved for treating alopecia areata, following approval of baricitinib (Olumiant) in June 2022 for alopecia...
Latest News
Warts difficult to eradicate in immunocompromised children
Warts completely resolved with treatment in only 24% of children undergoing active cancer treatment.
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
Latest News
Experts share their sun protection tips for children
Most sunscreens are not approved for use in children under the age of 6 months because testing has not been done in this age group, Dr. Adelaide A...
Pediatric Dermatology Consult
A 7-year-old male has a bumpy rash on the chin for several months
A 7-year-old male presents with a bumpy rash on the chin present for several months.
Latest News
IL-17 inhibitor approved in Europe for hidradenitis suppurativa
The manufacturer expects a regulatory decision from the U.S. Food and Drug Administration later this year.